Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 39

1.

Different Pearl Indices in studies of hormonal contraceptives in the United States: impact of study population.

Gerlinger C, Trussell J, Mellinger U, Merz M, Marr J, Bannemerschult R, Schellschmidt I, Endrikat J.

Contraception. 2014 Aug;90(2):142-6. doi: 10.1016/j.contraception.2014.03.018. Epub 2014 Apr 13.

2.

Effect of a low-dose contraceptive patch on efficacy, bleeding pattern, and safety: a 1-year, multicenter, open-label, uncontrolled study.

Wiegratz I, Bassol S, Weisberg E, Mellinger U, Merz M.

Reprod Sci. 2014 Dec;21(12):1518-25. doi: 10.1177/1933719114532840. Epub 2014 Apr 30.

PMID:
24784719
3.

Estradiol valerate plus dienogest versus ethinylestradiol plus levonorgestrel for the treatment of primary dysmenorrhea.

Petraglia F, Parke S, Serrani M, Mellinger U, Römer T.

Int J Gynaecol Obstet. 2014 Jun;125(3):270-4. doi: 10.1016/j.ijgo.2013.11.017. Epub 2014 Mar 11.

PMID:
24713413
4.

Efficacy and safety of a combined oral contraceptive containing estradiol valerate/dienogest: results from a clinical study conducted in North America.

Nelson A, Parke S, Mellinger U, Zampaglione E, Schmidt A.

J Womens Health (Larchmt). 2014 Mar;23(3):204-10. doi: 10.1089/jwh.2013.4320. Epub 2013 Nov 26.

PMID:
24279594
5.

Change to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunction.

Davis SR, Bitzer J, Giraldi A, Palacios S, Parke S, Serrani M, Mellinger U, Nappi RE.

J Sex Med. 2013 Dec;10(12):3069-79. doi: 10.1111/jsm.12310. Epub 2013 Sep 12.

PMID:
24034466
6.
7.

Efficacy and bleeding profile of a combined oral contraceptive containing oestradiol valerate/dienogest: a pooled analysis of three studies conducted in North America and Europe.

Nelson A, Parke S, Makalova D, Serrani M, Palacios S, Mellinger U.

Eur J Contracept Reprod Health Care. 2013 Aug;18(4):264-73. doi: 10.3109/13625187.2013.780202. Epub 2013 May 7.

PMID:
23651474
8.

Hormone withdrawal-associated symptoms: comparison of oestradiol valerate/dienogest versus ethinylestradiol/norgestimate.

Jensen JT, Parke S, Mellinger U, Serrani M, Mabey RG Jr.

Eur J Contracept Reprod Health Care. 2013 Aug;18(4):274-83. doi: 10.3109/13625187.2013.785516. Epub 2013 May 2.

PMID:
23638631
9.

Estimation of menstrual blood loss volume based on menstrual diary and laboratory data.

Schumacher U, Schumacher J, Mellinger U, Gerlinger C, Wienke A, Endrikat J.

BMC Womens Health. 2012 Aug 20;12:24. doi: 10.1186/1472-6874-12-24.

10.

Evaluation of the effects of rifampicin, ketoconazole and erythromycin on the steady-state pharmacokinetics of the components of a novel oral contraceptive containing estradiol valerate and dienogest in healthy postmenopausal women.

Blode H, Zeun S, Parke S, Zimmermann T, Rohde B, Mellinger U, Kunz M.

Contraception. 2012 Oct;86(4):337-44. doi: 10.1016/j.contraception.2012.01.010. Epub 2012 Mar 23.

PMID:
22445438
11.

Normalization of blood loss in women with heavy menstrual bleeding treated with an oral contraceptive containing estradiol valerate/dienogest.

Fraser IS, Jensen J, Schaefers M, Mellinger U, Parke S, Serrani M.

Contraception. 2012 Aug;86(2):96-101. doi: 10.1016/j.contraception.2011.11.011. Epub 2012 Jan 10.

PMID:
22240178
12.

Effective treatment of heavy and/or prolonged menstrual bleeding with an oral contraceptive containing estradiol valerate and dienogest: a randomized, double-blind Phase III trial.

Fraser IS, Römer T, Parke S, Zeun S, Mellinger U, Machlitt A, Jensen JT.

Hum Reprod. 2011 Oct;26(10):2698-708. doi: 10.1093/humrep/der224. Epub 2011 Jul 21.

13.

Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogest.

Fraser IS, Parke S, Mellinger U, Machlitt A, Serrani M, Jensen J.

Eur J Contracept Reprod Health Care. 2011 Aug;16(4):258-69. doi: 10.3109/13625187.2011.591456.

14.

Effect of extended-cycle regimen with an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on bleeding patterns, safety, acceptance and contraceptive efficacy.

Wiegratz I, Stahlberg S, Manthey T, Sänger N, Mittmann K, Lange E, Mellinger U, Palombo-Kinne E, Kuhl H.

Contraception. 2011 Aug;84(2):133-43. doi: 10.1016/j.contraception.2011.01.002. Epub 2011 Feb 21.

PMID:
21757054
15.

Metabolic and haemostatic effects of estradiol valerate/dienogest, a novel oral contraceptive: a randomized, open-label, single-centre study.

Junge W, Mellinger U, Parke S, Serrani M.

Clin Drug Investig. 2011;31(8):573-84. doi: 10.2165/11590220-000000000-00000.

PMID:
21721593
16.

Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus ethinylestradiol/levonorgestrel.

Klipping C, Duijkers I, Parke S, Mellinger U, Serrani M, Junge W.

Drugs R D. 2011;11(2):159-70. doi: 10.2165/11591200-000000000-00000.

17.

Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial.

Jensen JT, Parke S, Mellinger U, Machlitt A, Fraser IS.

Obstet Gynecol. 2011 Apr;117(4):777-87. doi: 10.1097/AOG.0b013e3182118ac3.

PMID:
21422847
18.

Effects of combined oral contraceptive ethinylestradiol (30 microg) and dienogest (2 mg) on carbohydrate metabolism during 1 year of conventional or extended-cycle use.

Wiegratz I, Stahlberg S, Manthey T, Sänger N, Mittmann K, Palombo-Kinne E, Mellinger U, Lange E, Kuhl H.

Horm Metab Res. 2010 May;42(5):358-63. doi: 10.1055/s-0030-1248263. Epub 2010 Mar 8.

PMID:
20213585
19.

Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on lipid metabolism during 1 year of conventional or extended-cycle use.

Wiegratz I, Stahlberg S, Manthey T, Sänger N, Mittmann K, Palombo-Kinne E, Mellinger U, Lange E, Kuhl H.

Contraception. 2010 Jan;81(1):57-61. doi: 10.1016/j.contraception.2009.07.011. Epub .

PMID:
20004274
20.

Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.

Ahrendt HJ, Makalová D, Parke S, Mellinger U, Mansour D.

Contraception. 2009 Nov;80(5):436-44. doi: 10.1016/j.contraception.2009.03.018. Epub 2009 May 13.

PMID:
19835717
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk